Frankfurt-am-Main, Germany

Marianne Siebert-Weigel


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **The Innovative Contributions of Marianne Siebert-Weigel**

Introduction

Marianne Siebert-Weigel, a prominent inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of pharmaceuticals. With her noteworthy patent, she has demonstrated her innovative spirit and dedication to advancing medical solutions.

Latest Patents

Siebert-Weigel holds a patent for "Piperazine derivatives, uses thereof and pharmaceutical compositions." This invention provides a unique set of compounds characterized by a general formula, featuring various combinations of hydroxyl groups and hydrogen atoms. These compounds also include pharmacologically acceptable salts and processes for their preparation and pharmaceutical uses. Her work opens new avenues for therapeutic applications, showcasing her expertise in medicinal chemistry.

Career Highlights

Throughout her career, Siebert-Weigel has been associated with Boehringer Mannheim GmbH, a leading pharmaceutical company known for its commitment to research and innovation. Her role within the company reflects her expertise and her impact on developing new pharmaceuticals.

Collaborations

Siebert-Weigel has collaborated with notable colleagues, including Gisbert Sponer and Harald D Borbe-Volmer. These partnerships highlight the collaborative nature of scientific research and the exchange of ideas that drive innovation forward in the field of pharmaceuticals.

Conclusion

Marianne Siebert-Weigel represents the merging of ingenuity and scientific inquiry, with her contributions to piperazine derivatives paving the way for new therapeutic developments. Her work at Boehringer Mannheim GmbH and her collaborations underscore the importance of teamwork in achieving breakthroughs in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…